Cargando…
A microchip platform for structural oncology applications
Recent advances in the development of functional materials offer new tools to dissect human health and disease mechanisms. The use of tunable surfaces is especially appealing as substrates can be tailored to fit applications involving specific cell types or tissues. Here we use tunable materials to...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003533/ https://www.ncbi.nlm.nih.gov/pubmed/27583302 http://dx.doi.org/10.1038/npjbcancer.2016.16 |
_version_ | 1782450666251223040 |
---|---|
author | Winton, Carly E Gilmore, Brian L Demmert, Andrew C Karageorge, Vasilea Sheng, Zhi Kelly, Deborah F |
author_facet | Winton, Carly E Gilmore, Brian L Demmert, Andrew C Karageorge, Vasilea Sheng, Zhi Kelly, Deborah F |
author_sort | Winton, Carly E |
collection | PubMed |
description | Recent advances in the development of functional materials offer new tools to dissect human health and disease mechanisms. The use of tunable surfaces is especially appealing as substrates can be tailored to fit applications involving specific cell types or tissues. Here we use tunable materials to facilitate the three-dimensional (3D) analysis of BRCA1 gene regulatory complexes derived from human cancer cells. We employed a recently developed microchip platform to isolate BRCA1 protein assemblies natively formed in breast cancer cells with and without BRCA1 mutations. The captured assemblies proved amenable to cryo-electron microscopy (EM) imaging and downstream computational analysis. Resulting 3D structures reveal the manner in which wild-type BRCA1 engages the RNA polymerase II (RNAP II) core complex that contained K63-linked ubiquitin moieties—a putative signal for DNA repair. Importantly, we also determined that molecular assemblies harboring the BRCA1(5382insC) mutation exhibited altered protein interactions and ubiquitination patterns compared to wild-type complexes. Overall, our analyses proved optimal for developing new structural oncology applications involving patient-derived cancer cells, while expanding our knowledge of BRCA1’s role in gene regulatory events. |
format | Online Article Text |
id | pubmed-5003533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50035332016-08-29 A microchip platform for structural oncology applications Winton, Carly E Gilmore, Brian L Demmert, Andrew C Karageorge, Vasilea Sheng, Zhi Kelly, Deborah F NPJ Breast Cancer Article Recent advances in the development of functional materials offer new tools to dissect human health and disease mechanisms. The use of tunable surfaces is especially appealing as substrates can be tailored to fit applications involving specific cell types or tissues. Here we use tunable materials to facilitate the three-dimensional (3D) analysis of BRCA1 gene regulatory complexes derived from human cancer cells. We employed a recently developed microchip platform to isolate BRCA1 protein assemblies natively formed in breast cancer cells with and without BRCA1 mutations. The captured assemblies proved amenable to cryo-electron microscopy (EM) imaging and downstream computational analysis. Resulting 3D structures reveal the manner in which wild-type BRCA1 engages the RNA polymerase II (RNAP II) core complex that contained K63-linked ubiquitin moieties—a putative signal for DNA repair. Importantly, we also determined that molecular assemblies harboring the BRCA1(5382insC) mutation exhibited altered protein interactions and ubiquitination patterns compared to wild-type complexes. Overall, our analyses proved optimal for developing new structural oncology applications involving patient-derived cancer cells, while expanding our knowledge of BRCA1’s role in gene regulatory events. Nature Publishing Group 2016-06-15 /pmc/articles/PMC5003533/ /pubmed/27583302 http://dx.doi.org/10.1038/npjbcancer.2016.16 Text en Copyright © 2016 Breast Cancer Research Foundation/Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Winton, Carly E Gilmore, Brian L Demmert, Andrew C Karageorge, Vasilea Sheng, Zhi Kelly, Deborah F A microchip platform for structural oncology applications |
title | A microchip platform for structural oncology applications |
title_full | A microchip platform for structural oncology applications |
title_fullStr | A microchip platform for structural oncology applications |
title_full_unstemmed | A microchip platform for structural oncology applications |
title_short | A microchip platform for structural oncology applications |
title_sort | microchip platform for structural oncology applications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003533/ https://www.ncbi.nlm.nih.gov/pubmed/27583302 http://dx.doi.org/10.1038/npjbcancer.2016.16 |
work_keys_str_mv | AT wintoncarlye amicrochipplatformforstructuraloncologyapplications AT gilmorebrianl amicrochipplatformforstructuraloncologyapplications AT demmertandrewc amicrochipplatformforstructuraloncologyapplications AT karageorgevasilea amicrochipplatformforstructuraloncologyapplications AT shengzhi amicrochipplatformforstructuraloncologyapplications AT kellydeborahf amicrochipplatformforstructuraloncologyapplications AT wintoncarlye microchipplatformforstructuraloncologyapplications AT gilmorebrianl microchipplatformforstructuraloncologyapplications AT demmertandrewc microchipplatformforstructuraloncologyapplications AT karageorgevasilea microchipplatformforstructuraloncologyapplications AT shengzhi microchipplatformforstructuraloncologyapplications AT kellydeborahf microchipplatformforstructuraloncologyapplications |